Caris private stock trade

Caris

Legal NameCaris MPI, Inc.
HeadquartersIrving, CA
SectorBioTech

Caris is a precision medicine company that specializes in molecular profiling and genomics. The company is dedicated to helping healthcare providers make more informed and personalized treatment decisions for cancer patients. Caris analyzes tumor tissue and provides molecular information, including genetic and molecular alterations, to assist oncologists in tailoring targeted therapies and treatment plans specific to each patient's unique genetic makeup. By offering insights into the genetic drivers of cancer, Caris aims to improve the effectiveness of cancer treatments.

Learn more about Caris IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Caris, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Caris, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.